Highly Regarded by Multiple Institutions, CRISPR Therapeutics Leads Gene Editing Therapy with a Diverse Pipeline Life Science
Eli Lilly’s Strong Oral Weight-Loss Drug Data Solidifies Its Leading Position in the GLP-1 Market Life Science
Winning Investor Favor, Alibaba Successfully Raises $3.2 Billion to Boost Cloud and International Businesses Technology